Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 14/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 14/20 | 0.45 |
| ▸ | DRD2 | P14416 | 12/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3557151 | 1.00 | DRD3 (0.45) | DRD3KCNH2DRD2CYP2C19ADRA1D | |
| SCHEMBL13314202 | 1.00 | DRD3 (0.45) | DRD3KCNH2DRD2CYP2C19ADRA1D | |
| SCHEMBL15196038 | 1.00 | DRD3 (0.45) | DRD3KCNH2DRD2CYP2C19ADRA1D | |
| SCHEMBL10120660 | 0.89 | DRD3 (0.46) | DRD3KCNH2DRD2 | |
| SCHEMBL2745493 | 0.89 | DRD3 (0.46) | DRD3KCNH2DRD2 | |
| SCHEMBL13882099 | 0.89 | DRD3 (0.46) | DRD3KCNH2DRD2 | |
| SCHEMBL10107813 | 0.89 | DRD3 (0.46) | DRD3KCNH2DRD2 | |
| SCHEMBL13349019 | 0.88 | DRD2 (0.49) | DRD3KCNH2DRD2CYP2C19ADRA1D | |
| SCHEMBL13314297 | 0.88 | DRD2 (0.49) | DRD3KCNH2DRD2CYP2C19ADRA1D | |
| SCHEMBL3564326 | 0.88 | DRD2 (0.49) | DRD3KCNH2DRD2CYP2C19ADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2007750-A1 | AZABICYCLO [3. 1. 0] HEXYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007113232-A1 | AZABICYCLO [3. 1. 0] HEXYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS | GLAXO GROUP LIMITED (GB) | 2007-10-11 | — | — | WO | disclosed |